Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Transplantation|February 1, 1988
Individualization of immediate posttransplant immunosuppression. The value of antilymphocyte globulin in patients with delayed graft functionA J Matas, V A Tellis, T A Quinn, et al.
The Journal of Surgical Research|June 1, 1994
Prolonged use of cyclosporine (CsA) produces reversible hemodynamic and absorptive alterations in the transplanted rat small intestineS M Greenstein, S Sun, R S Schechner, et al.
Tissue Antigens|February 11, 2012
Distinct distribution of killer-cell immunoglobulin-like receptor genes in the Mugil and Ilaita areas of Papua New GuineaE John, F T Christiansen, I Mueller, et al.
Clinical Transplants|September 30, 1999
Renal transplantation in a heterogeneous population: the thirty-year Montefiore Medical Center experienceS M Greenstein, D Kim, A Principe, et al.
Transplantation|August 29, 1998
Chronic renal allograft rejection: no response to mycophenolate mofetilD Glicklich, B Gupta, G Schurter-Frey, et al.
Cancer Research|January 15, 1987
Ethylnitrosourea-induced transplacental carcinogenesis in the mouse: tumor response, DNA binding, and adduct formationD G Branstetter, G D Stoner, H A Schut, et al.
Bone Marrow Transplantation|July 19, 2005
Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AMLJ Y Sun, L Gaidulis, A Dagis, et al.
Transplantation|February 1, 1990
Evidence that zero antigen-matched cyclosporine-treated renal transplant recipients have graft survival equal to that of matched recipients. Reevaluation of pointsS M Greenstein, R S Schechner, P Louis, et al.
Tissue Antigens|September 14, 2004
Development of a multiplex PCR-SSP method for Killer-cell immunoglobulin-like receptor genotypingJ Y Sun, L Gaidulis, M M Miller, et al.
Tissue Antigens|February 3, 2012
Genetic variations in loci relevant to natural killer cell function are affected by ethnicity but are generally not correlated with susceptibility to HIV-1M Z K A Aghafar, C Witt, A Kamarulzaman, et al.
Pageof 8